Walter Kalmans

Walter Kalmans is the President and founder of Lontra Ventures, a company he established in 2008.1 He leads the Life Sciences Division, specializing in business development, product strategy, marketing, national accounts, and channel management for life science companies.1

Prior to founding Lontra Ventures, Kalmans served as Vice President of Business Development for Oncology Therapeutics Network (OTN), a subsidiary of McKesson Corporation.1 He has also held senior commercial positions at Vignette and Becton Dickinson & Company, and worked as a healthcare management consultant for firms like Quintiles, Booz-Allen & Hamilton, and Accenture.1

Kalmans has a strong educational background, holding a Bachelor of Science in Finance from the Wharton School and a Bachelor of Arts in Molecular Biology from the College of Arts & Sciences at the University of Pennsylvania.1 He also earned an MBA from Duke University's Fuqua School of Business, graduating as a JB Fuqua Scholar.1

In addition to his professional work, Kalmans is active in the industry, speaking at conferences, being quoted in publications, and even testifying before Congress on health policy issues.1 He is also a guest blogger for The University of Texas McCombs School of Business and The Wharton School at The University of Pennsylvania.1

On social media, Walter Kalmans describes himself as a pharmaceutical executive with deep specialty drug expertise, particularly in oncology, immunology, and neurology.2